DK38293D0 - Fremstilling af proteiner - Google Patents

Fremstilling af proteiner

Info

Publication number
DK38293D0
DK38293D0 DK93382A DK38293A DK38293D0 DK 38293 D0 DK38293 D0 DK 38293D0 DK 93382 A DK93382 A DK 93382A DK 38293 A DK38293 A DK 38293A DK 38293 D0 DK38293 D0 DK 38293D0
Authority
DK
Denmark
Prior art keywords
proteins
preparation
Prior art date
Application number
DK93382A
Other languages
English (en)
Inventor
Tony Joergensen
Anders Hjelholt Pedersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK93382A priority Critical patent/DK38293D0/da
Publication of DK38293D0 publication Critical patent/DK38293D0/da
Priority to TW083102182A priority patent/TW278079B/zh
Priority to ZA941956A priority patent/ZA941956B/xx
Priority to CZ952533A priority patent/CZ253395A3/cs
Priority to CN94191833A priority patent/CN1039231C/zh
Priority to CA002159313A priority patent/CA2159313A1/en
Priority to EP94911854A priority patent/EP0691984A1/en
Priority to PCT/DK1994/000122 priority patent/WO1994022905A1/en
Priority to US08/446,671 priority patent/US5700914A/en
Priority to AU64239/94A priority patent/AU677309B2/en
Priority to PL94310887A priority patent/PL310887A1/xx
Priority to HU9502846A priority patent/HUT72712A/hu
Priority to FI954649A priority patent/FI954649A0/fi
Priority to JP6521552A priority patent/JPH08508264A/ja
Priority to IL10916494A priority patent/IL109164A0/xx
Priority to NO953883A priority patent/NO953883L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Catalysts (AREA)
DK93382A 1993-03-31 1993-03-31 Fremstilling af proteiner DK38293D0 (da)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner
TW083102182A TW278079B (da) 1993-03-31 1994-03-14
ZA941956A ZA941956B (en) 1993-03-31 1994-03-21 Purification of factor VII
JP6521552A JPH08508264A (ja) 1993-03-31 1994-03-24 Ｖｉｉ因子の精製
EP94911854A EP0691984A1 (en) 1993-03-31 1994-03-24 Purification of factor vii
CN94191833A CN1039231C (zh) 1993-03-31 1994-03-24 因子vii的纯化
CA002159313A CA2159313A1 (en) 1993-03-31 1994-03-24 Purification of factor vii
CZ952533A CZ253395A3 (en) 1993-03-31 1994-03-24 Method of controlled activation and degradation of factor vii during purification process
PCT/DK1994/000122 WO1994022905A1 (en) 1993-03-31 1994-03-24 Purification of factor vii
US08/446,671 US5700914A (en) 1993-03-31 1994-03-24 Purification of Factor VII
AU64239/94A AU677309B2 (en) 1993-03-31 1994-03-24 Purification of factor VII
PL94310887A PL310887A1 (en) 1993-03-31 1994-03-24 Proncovertin purification method
HU9502846A HUT72712A (en) 1993-03-31 1994-03-24 Purification of factor vii
FI954649A FI954649A0 (fi) 1993-03-31 1994-03-24 Hyytymistekijä VII:n puhdistus
IL10916494A IL109164A0 (en) 1993-03-31 1994-03-30 Purification of factor VII
NO953883A NO953883L (no) 1993-03-31 1995-09-29 Rensing av faktor VII

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner

Publications (1)

Publication Number Publication Date
DK38293D0 true DK38293D0 (da) 1993-03-31

Family

ID=8092871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner

Country Status (16)

Country Link
US (1) US5700914A (da)
EP (1) EP0691984A1 (da)
JP (1) JPH08508264A (da)
CN (1) CN1039231C (da)
AU (1) AU677309B2 (da)
CA (1) CA2159313A1 (da)
CZ (1) CZ253395A3 (da)
DK (1) DK38293D0 (da)
FI (1) FI954649A0 (da)
HU (1) HUT72712A (da)
IL (1) IL109164A0 (da)
NO (1) NO953883L (da)
PL (1) PL310887A1 (da)
TW (1) TW278079B (da)
WO (1) WO1994022905A1 (da)
ZA (1) ZA941956B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
KR100960211B1 (ko) 1998-05-06 2010-05-27 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
DE60138364D1 (de) 2000-02-11 2009-05-28 Bayer Healthcare Llc Gerinnungsfaktor vii oder viia konjugate
AU2002351756A1 (en) 2001-12-21 2003-07-15 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
AU2003240438A1 (en) 2002-06-21 2004-01-06 Novo Nordisk A/S Stabilised solid compositions of factor vii polypeptides
EP1611236A1 (en) 2003-03-18 2006-01-04 Novo Nordisk Health Care AG Method for the production of gla-residue containing serine proteases
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
BRPI0409936A (pt) * 2003-05-23 2006-04-25 Novo Nordisk Healthcare Ag uso de um material, recipiente pelo menos parcialmente cheio, e, kit médico
ATE547114T1 (de) * 2003-06-25 2012-03-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzungen von factor vii polypeptiden
JP5306597B2 (ja) * 2003-07-01 2013-10-02 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液体水性薬学的組成物
CA2534028A1 (en) 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
AU2004294403A1 (en) 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor VII solutions to remove virus
KR20130026498A (ko) * 2003-12-19 2013-03-13 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｖｉｉ 폴리펩티드의 안정화된 조성물
AU2005318106B2 (en) * 2004-12-23 2011-11-03 Novo Nordisk Health Care Ag Reduction of the content of protein contaminants in compositions comprising a Vitamin K-dependent protein of interest
ATE476501T1 (de) * 2005-01-14 2010-08-15 Bayer Healthcare Llc Verfahren zur reinigung von factor vii
PL1907540T3 (pl) * 2005-07-22 2013-05-31 Bayer Healthcare Llc Aktywacja czynnika VII w roztworze
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
ES2779992T3 (es) * 2005-12-20 2020-08-21 Univ Duke Métodos y composiciones para suministrar agentes activos con propiedades farmacológicas potenciadas
WO2009158704A2 (en) 2008-06-27 2009-12-30 Duke University Therapeutic agents comprising elastin-like peptides
CN103539852B (zh) * 2012-07-12 2015-08-12 上海泰龙生物医药科技有限公司 一种从细胞培养液中分离纯化重组人凝血八因子的方法
EP2687595B1 (en) * 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
WO2014062879A2 (en) 2012-10-17 2014-04-24 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
AU2017381677B2 (en) 2016-12-22 2019-10-03 Km Biologics Co., Ltd. Chromatographic method for collecting blood coagulation factor VII with high yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
HU9502846D0 (en) 1995-12-28
AU677309B2 (en) 1997-04-17
CA2159313A1 (en) 1994-10-13
AU6423994A (en) 1994-10-24
TW278079B (da) 1996-06-11
FI954649A7 (fi) 1995-09-29
HUT72712A (en) 1996-05-28
JPH08508264A (ja) 1996-09-03
FI954649L (fi) 1995-09-29
IL109164A0 (en) 1994-06-24
CN1121723A (zh) 1996-05-01
CZ253395A3 (en) 1996-01-17
CN1039231C (zh) 1998-07-22
US5700914A (en) 1997-12-23
PL310887A1 (en) 1996-01-08
FI954649A0 (fi) 1995-09-29
WO1994022905A1 (en) 1994-10-13
NO953883D0 (no) 1995-09-29
ZA941956B (en) 1994-09-30
EP0691984A1 (en) 1996-01-17
NO953883L (no) 1995-11-28

Similar Documents

Publication Publication Date Title
DK38293D0 (da) Fremstilling af proteiner
DK180790A (da) Fremstilling af farmaceutisk praeparat
DE69434520D1 (de) Biotinylierung von proteinen
FI952574A7 (fi) Glykosyylitransferaasiaktiiviset proteiinit
DK132892D0 (da) Proteiner
DK0537786T3 (da) Fremstilling af en N-acylaminomethylphosphonsyre
DK0490936T3 (da) Fremstilling af triazolinoner
DK549688A (da) Fremstilling af peptider
DK273089D0 (da) Anvendelse af peptidderivater
DK0792253T3 (da) Fremstilling af 11C-methyliodid
DK93793D0 (da) Fremgangsmaade til fremstilling af naturlige maelkeproteiner
DK0689577T3 (da) Anvendelse af ferroncen
DK82592D0 (da) Fremstilling af proteiner
DK0648748T3 (da) Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2
DK104489A (da) Anvendelse af triazolderivater
DK53792D0 (da) Fremgangsmaade til fremstilling af proteiner
DK0589626T3 (da) Fremstilling af beta-methylcarbapenem-mellemprodukter
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
DK88093D0 (da) Stabilt praeparat
DK135387D0 (da) Fremstilling af proteiner
DK149591D0 (da) Proteinpraeparat
SV1993000010A (es) Preparacion de nuevas sulfonamidocarboxamidas
DK2292D0 (da) Oprensning af aeggeproteiner
DK103393D0 (da) Praeparat
DK76093D0 (da) Anvendelse af glycosider